Status unknownNCT04426942Updated Jun 11, 2020

Sexuality in Medically Assisted Procreation Pregnancies

An observational study in Pregnancy Related and Assisted Reproduction, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-11.

Sponsored by Central Hospital, Nancy, France · Observational

The sponsor has not verified this record recently (last verified Jun 2020), so the status shown — last known as Recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 350
Ages: 18 Years and older
Sex: Female

Study summary

We wish to evaluate sexuality during pregnancy between spontaneous pregnancies and resulting from assisted procreation The literature is poor on thie subject

Conditions studied

Pregnancy Related
Assisted Reproduction

Keywords

assisted reproduction

In context

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: Female
Sampling method: Non-probability sample

Study population

Pregnant women

Inclusion criteria

physiological pregnancy
pregnancy from assisted reproduction
age over 18
to understand french
patient's agreement

Exclusion criteria

Exclusion Criteria:

pathological pregnancy

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 350 participants (estimated)
Patient registry: No

Groups and cohorts

Spontaneous pregnancy
Other: survey
Assisted reproduction pregnancy
Other: survey

Interventions

Othersurvey
survey on sexuality during pregnancy

What researchers measure

Primary outcomes

Evaluation of sexual functioning with Female Sexual Function Index (FSFI) test
Time frame: In the second trimester of the pregnancy

Study locations

1 of 1 sites recruiting

Matthieu Dap
Nancy, 54000, France
- Matthieu Dap · Contact · m.dap@chru-nancy.fr · 0630736896
Recruiting

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jun 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT04426942
Lead sponsor: Central Hospital, Nancy, France
Responsible party: Matthieu DAP (Docteur, Central Hospital, Nancy, France) — Principal investigator
First posted: Jun 11, 2020
Start date: Jun 20, 2020 (estimated)
Primary completion: Sep 2020 (estimated)
Completion: Dec 2020 (estimated)
Last update: Jun 11, 2020

Oversight

Data monitoring committee: Yes
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Central Hospital, Nancy, France

Start the discussion